Skip to main content
Erschienen in: Cardiovascular Intervention and Therapeutics 1/2018

21.11.2016 | Original Article

Evaluation for the efficacy and safety of the crosser catheter as a CTO crossing device and a flossing device

verfasst von: Michinao Tan, Kazushi Urasawa, Ryoji Koshida, Takuya Haraguchi, Shunsuke Kitani, Yuya Nakagawa, Yasumi Igarashi, Katsuhiko Sato

Erschienen in: Cardiovascular Intervention and Therapeutics | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

The Crosser catheter is a unique device that facilitates antegrade intraluminal recanalization by high-frequency vibration energy and cavitation. We used this device not only as a chronic total occlusion (CTO) crossing device, but also as a flossing device in stenotic lesions and we also evaluated the efficacy of this device when used with both the “Crosser preceding” and the “Guidewire preceding” in CTOs. Complications related to this device were investigated, too. We retrospectively analyzed a total of 90 consecutive patients with peripheral artery disease in the femoropopliteal artery and below-the-knee artery (BTA). Primary technical success was defined as the successful delivery of this device into the distal true lumen. Secondary technical success was defined as successful revascularization. The safety endpoints were events of angiographic complications, including the occurrence of detachment of the metal tip from the shaft, slow flow, dissections, and perforations. Overall primary technical success rate was 93.3% and the secondary technical success rate was 96.7%. Detachment and slow flow occurred 14.4 and 4.4%, respectively, with no occurrences of either dissection or perforation. A predictor of detachment was Proposed Peripheral Arterial Calcium Scoring System (PACSS) grade 4 (OR 14.6; CI 1.26–168.5; P = 0.032). The Crosser catheter is useful not only as a CTO crossing device used with both the “Crosser preceding” and the “Guidewire preceding”, but also as a flossing device in stenotic lesions. But we have to pay attention to complications related to the Crosser.
Literatur
1.
Zurück zum Zitat Shin SH, Baril D, Chaer R, et al. Limitations of the Outback LTD re-entry device in femoropopliteal chronic total occlusions. J Vasc Surg. 2011;53:1260–4.CrossRefPubMed Shin SH, Baril D, Chaer R, et al. Limitations of the Outback LTD re-entry device in femoropopliteal chronic total occlusions. J Vasc Surg. 2011;53:1260–4.CrossRefPubMed
2.
Zurück zum Zitat Joye J. The PATRIOT (peripheral approach to recanalization in occluded totals) study results. Am J Cardiol. 2007;100(Supp 1):S24. Joye J. The PATRIOT (peripheral approach to recanalization in occluded totals) study results. Am J Cardiol. 2007;100(Supp 1):S24.
3.
Zurück zum Zitat Adam DJ, Bradbury AW. TASCII document on the management of peripheral artery disease. Eur J Vasc Endovasc Surg. 2007;33(1):1–2.CrossRefPubMed Adam DJ, Bradbury AW. TASCII document on the management of peripheral artery disease. Eur J Vasc Endovasc Surg. 2007;33(1):1–2.CrossRefPubMed
4.
Zurück zum Zitat Staniloae CS, Mody KP, et al. Endoluminal treatment of peripheral chronic total occlusions using the Crosser recanalization catheter. J Invasive Cardiol. 2011;23:359–62.PubMed Staniloae CS, Mody KP, et al. Endoluminal treatment of peripheral chronic total occlusions using the Crosser recanalization catheter. J Invasive Cardiol. 2011;23:359–62.PubMed
5.
Zurück zum Zitat Gandini R, Volpi T, Pititone V, et al. Intraluminal recanalization of long infrainguinal chronic total occlusions using the Crosser system. J Endovasc Ther. 2009;16:23–7.CrossRefPubMed Gandini R, Volpi T, Pititone V, et al. Intraluminal recanalization of long infrainguinal chronic total occlusions using the Crosser system. J Endovasc Ther. 2009;16:23–7.CrossRefPubMed
6.
Zurück zum Zitat Igari K, Kudo T, Toyofuku T, Inoue Y, et al. A novel approach to infrainguinal arteries with chronic total occlusions using the high frequency vibrational device. Int Angiol. 2016;35(2):212–6.PubMed Igari K, Kudo T, Toyofuku T, Inoue Y, et al. A novel approach to infrainguinal arteries with chronic total occlusions using the high frequency vibrational device. Int Angiol. 2016;35(2):212–6.PubMed
7.
Zurück zum Zitat Khalid MR, Khalid FR, Farooqui FA, et al. A novel catheter in patients with peripheral chronic total occlusions: a single center experience. Catheter Cardiovasc Interv. 2010;76(5):735–9.CrossRefPubMed Khalid MR, Khalid FR, Farooqui FA, et al. A novel catheter in patients with peripheral chronic total occlusions: a single center experience. Catheter Cardiovasc Interv. 2010;76(5):735–9.CrossRefPubMed
Metadaten
Titel
Evaluation for the efficacy and safety of the crosser catheter as a CTO crossing device and a flossing device
verfasst von
Michinao Tan
Kazushi Urasawa
Ryoji Koshida
Takuya Haraguchi
Shunsuke Kitani
Yuya Nakagawa
Yasumi Igarashi
Katsuhiko Sato
Publikationsdatum
21.11.2016
Verlag
Springer Japan
Erschienen in
Cardiovascular Intervention and Therapeutics / Ausgabe 1/2018
Print ISSN: 1868-4300
Elektronische ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-016-0444-7

Weitere Artikel der Ausgabe 1/2018

Cardiovascular Intervention and Therapeutics 1/2018 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.